104 related articles for article (PubMed ID: 5342122)
21. [Current status and future perspective of new drugs for hematological malignancies in Japan].
Ogura M
Rinsho Ketsueki; 2007 Oct; 48(10):1442-52. PubMed ID: 17933133
[No Abstract] [Full Text] [Related]
22. The current status of cancer chemotherapy for selected human neoplasms.
Rubin RN
Clin Ther; 1981; 4(2):74-94. PubMed ID: 7028265
[No Abstract] [Full Text] [Related]
23. [Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Masaoka T; Kimura K; Miyazaki T; Sakurada K; Saitoh H; Morioka M; Fujimoto N; Musashi M; Wakui A; Yokoyama M; Kanamaru R; Oguro M; Takagi T; Konda C; Saitoh T; Nakao I; Harashima S; Ohhashi Y; Sakai Y; Sasaki T; Ohno R; Katoh Y; Yamada K; Hirota Y; Takada T; Hoshino A; Ohara K; Kamiya O; Kojima T; Nagata K; Nakamura T; Sasada M; Yonezawa T; Tsubakio T; Kanayama Y; Kitani T; Taniguchi N; Yasunaga K; Okamoto Y; Fujitake H; Ohkubo A; Horiuchi A; Tsubaki K; Takubo T; Shibata H; Kawagoe H; Hirata M; Matsubuchi T; Nagai K; Fujita S
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1518-23. PubMed ID: 6347081
[TBL] [Abstract][Full Text] [Related]
24. [Optimising therapy in patients with haematological malignancies].
Dumontet C
Bull Cancer; 2008 Oct; 95(10):959-62. PubMed ID: 19004726
[TBL] [Abstract][Full Text] [Related]
25. [Protocols for the treatment of leukemia and lymphoma: toward escalation or toward reduction of degree?].
Mathé G; Misset JL; Machover D; Schwarzenberg L; Timus M; Jasmin C; Ribaud P; Musset M
Biomed Pharmacother; 1984; 38(1):13-32. PubMed ID: 6380605
[TBL] [Abstract][Full Text] [Related]
26. A Plethora of Novel Therapies--Which One to Choose?
Cohen JB; Flowers CR
Oncology (Williston Park); 2015 Jul; 29(7):499-500. PubMed ID: 26178343
[No Abstract] [Full Text] [Related]
27. [Quantitative measurement and clinical analysis of serum levels of immunosuppressive acidic protein (IAP) in hematopoietic malignancies].
Hamaguchi H; Karitani Y; Minami N; Tanaka I; Iwata Y; Shirakawa S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1231-6. PubMed ID: 6732251
[TBL] [Abstract][Full Text] [Related]
28. [Angiogenesis and hematological malignancies].
Iversen PO
Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3198-200. PubMed ID: 14714007
[TBL] [Abstract][Full Text] [Related]
29. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
[TBL] [Abstract][Full Text] [Related]
30. [Interferons in the treatment of hematological diseases].
Jantunen E; Nousiainen T
Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
[No Abstract] [Full Text] [Related]
31. Battling the hematological malignancies: the 200 years' war.
Lichtman MA
Oncologist; 2008 Feb; 13(2):126-38. PubMed ID: 18305057
[TBL] [Abstract][Full Text] [Related]
32. The Ommaya reservoir in chemotherapy for malignant disease in the CNS.
Jacobs A; Clifford P; Kay HE
Clin Oncol; 1981 Jun; 7(2):123-9. PubMed ID: 7249435
[No Abstract] [Full Text] [Related]
33. Interferons for malignant blood diseases?
Hokland M; Hokland P
Eur J Haematol; 1987 Mar; 38(3):209-12. PubMed ID: 2439370
[No Abstract] [Full Text] [Related]
34. Targeting Wnt pathway in lymphoma and myeloma cells.
Schmidt M; Sievers E; Endo T; Lu D; Carson D; Schmidt-Wolf IG
Br J Haematol; 2009 Mar; 144(5):796-8. PubMed ID: 19036118
[No Abstract] [Full Text] [Related]
35. [Clinical development of a proteasome inhibitor, bortezomib, for the treatment of myeloma and lymphoma].
Tobinai K
Rinsho Ketsueki; 2007 Jun; 48(6):451-7. PubMed ID: 17633092
[No Abstract] [Full Text] [Related]
36. Metabolic complications of induction therapy for leukemia and lymphoma.
Cohen DG
Cancer Nurs; 1983 Aug; 6(4):307-10. PubMed ID: 6554111
[No Abstract] [Full Text] [Related]
37. Clinical trials refferal resource. Current clinical trials of new agents and novel therapies in pediatric leukemia and lymphoma.
Smith MA; Schoenfeldt M
Oncology (Williston Park); 2003 Oct; 17(10):1377, 1380, 1383-4. PubMed ID: 14606363
[No Abstract] [Full Text] [Related]
38. Mortality trend of hematologic and lymphatic malignancy (lymphoma, multiple myeloma and leukemia) in Japan: 1960-2000.
Yoshimi I; Kaneko S
Jpn J Clin Oncol; 2004 Apr; 34(4):218-25. PubMed ID: 15190904
[No Abstract] [Full Text] [Related]
39. [Incidence of malignant lymphoma and leukemias in East Germany].
Berndt H; Hendel V
Z Gesamte Inn Med; 1984 Mar; 39(5):73-6. PubMed ID: 6586015
[TBL] [Abstract][Full Text] [Related]
40. Anthracycline-induced cardiotoxicity in adult hematologic malignancies.
Johnson SA
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S22-7. PubMed ID: 16781286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
